Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 2, 2007, Pages 135-142

  Vollmer, William M ^a   Peters, Dawn ^b   Crane, Bradley ^a   Kelleher, Christopher ^a   Buist, A Sonia ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; COPD; Health care utilization; Inhaled corticosteroids; Mortality; Observational study; Survival analysis

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; THEOPHYLLINE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEATH; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SENSITIVITY ANALYSIS; DRUG ADMINISTRATION; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; SMOKING; STATISTICS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; AGED; ASTHMA; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME;

EID: 34547402141     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701341186     Document Type: Article

References (31)

1. Sin DD, Man SFP. Inhaled corticosteroids in the long-term management of elderly patients with Chronic Obstructive Pulmonary Disease. Drugs Aging 2003; 20:867-880.
2. Soriano JB, Kiri VA, Pride NB, Vestbo J. Inhaled corticosteroids with/without long-acting B-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med 2003; 2(1):67-74.
3. Soriano JB, Vestbo J, Pride NB, Kiri VA, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20:819-825.
4. Kiri VA, Vestbo J, Pride NB, Soriano JB. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 2004; 24:190-191.
5. de Melo MN, Ernst P, Suissa S. Inhaled corticosteroids and the risk of a first exacerbation in COPD patients. Eur Respir J 2004; 23:692-697.
6. Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med 2003; 168:1488-1494.
7. Burney P, Suissa S, Soriano JB, Vollmer WM, Viegi G, Sullivan SD, Fabbri LM, Sin DD, Ernst P, Coultas D, Bourbeau J, Mapel DW, Weiss K, McLaughlin T, Price D, Sturkenboom MC, Taylor R, Hagan GW. The pharmacoepidemiology of COPD: recent advances and methodological discussion. Eur Respir J Suppl 2003; 43:1s-44s.
8. Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003; 168:49-53.
9. Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 2003; 58:937-941.
10. Burge PS, Lewis SA. So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all? Thorax 2003; 58:911-913.
11. Samet JM. Measuring the effectiveness of inhaled corticosteroids for COPD is not easy! Am J Respir Crit Care Med 2003; 168:1-2.
12. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission In elderly patients with chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 164:580-584.
13. Kiri VA, Pride NB, Soriano JB, Vestbo J. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med 2005; 172:460-464.
14. Sin DD, Man SFP. Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur Respir J 2003; 21:260-266.
15. Bourbeau J. Inhaled corticosteroids and survival in chronic obstructive pulmonary disease. Eur Respir J 2003; 21:202-203.
16. Bourbeau J, Ernst P, Cockcoft D, Suissa S. Inhaled corticosteroids and hospitalisation due to exacerbation of COPD. Eur Respir J 2003; 22:286-289.
17. Suissa S. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 2004; 23(3):391-395.
18. Suissa S. Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease: misconstrued immortal time bias. Am J Respir Crit Care Med 2006; 173(4):464-465.
19. Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman DJ, O'Keeffe Rosetti MC. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care 2003; 41:84-99.
20. Alaniz KL, Nordstrand J. Camp Superteens. An asthma education program for adolescents. MCN Am J Matern Child Nurs 1999; 24:133-137.
21. Osborne ML, Vollmer WM, Buist AS. Diagnostic accuracy of asthma within a health maintenance organization. J Clin Epidemiology 1992; 45:403-411.
22. Mapel DW. Treatment implications on morbidity and mortality in COPD. Chest 2004; 126:150S-158S.
23. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005; 32:367-372.
24. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308-1311.
25. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60:282-287.
26. Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 2004; 363:731-733.
27. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fagan JK, Fish JE, Ford JG, Kraft M, Lemanske RF, Jr., Leone FT, Martin RJ, Mauger EA, Pesola GR, Peters SP, Rollings NJ, Szefler SJ, Wechsler ME, Israel E. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352:1519-1528.
28. Global Strategy for Asthma Management and Prevention. 〈http://www.ginasthma.com/〉. 2005. NIH Publication No. 02-3659.
29. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574-580.
30. Sin DD, Man SF. Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease? Eur Respir J 2005; 25:589-590.
31. Huiart L, Ernst P, Ranouil X, Suissa S. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 2005; 25:634-639.